Steel Peak Wealth Management LLC Biomarin Pharmaceutical Inc Transaction History

Steel Peak Wealth Management LLC

  • $2.12 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024
BUY
$83.81 - $99.0 $20,617 - $24,354
246 Added 10.92%
2,498 $218,000
Q4 2023

Jan 23, 2024
BUY
$76.22 - $98.51 $171,647 - $221,844
2,252 New
2,252 $217,000
Q2 2023

Aug 02, 2023
SELL
$86.68 - $100.3 $236,289 - $273,417
-2,726 Reduced 34.81%
5,106 $442,000
Q1 2023

May 05, 2023
BUY
$87.74 - $117.27 $309,809 - $414,080
3,531 Added 82.1%
7,832 $761,000
Q4 2022

Jan 25, 2023
BUY
$80.93 - $108.63 $348,079 - $467,217
4,301 New
4,301 $0

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Steel Peak Wealth Management LLC Portfolio

Follow Steel Peak Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steel Peak Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steel Peak Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email